Andrea C. King

Research Summary
Clinical Interests Assessment and treatment of substance use disorders Tobacco and alcohol addictions in medical and psychiatric patients. Cancer prevention and control. Research Interests Identifying risk factors, biological vulnerability, and co-morbidities in substance use disorders. Examining efficacy of behavioral and pharmacological treatments for nicotine, alcohol, and other addictive disorders. Targeting treatments for minority and underserved smokers.
  • University of Oklahoma Health Sciences Center, Ph.D. 1992
  • University of Pennsylvania, Post-doctoral Fellowship 1994
  • New York Medical College, St. Vincent’s Hospital, Internship 1995
  • Illinois Licensed Clinical Psychologist
Biosciences Graduate Program Association
  1. Brett EI, Miloslavich K, Vena A, Didier N, King AC. Effects of Visual Exposure to IQOS Use on Smoking Urge and Behavior. Tob Regul Sci. 2021 Jan; 7(1):31-45. View in: PubMed

  2. King AC, Brett EI, Vena A, Miloslavich K, Cao D. Electronic nicotine delivery systems (ENDS) cue reactivity in dual users: A combined analysis. Drug Alcohol Depend. 2021 Oct 01; 227:108909. View in: PubMed

  3. Fridberg DJ, Cao D, King AC. Alcohol subjective responses in heavy drinkers: Measuring acute effects in the natural environment versus the controlled laboratory setting. Alcohol Clin Exp Res. 2021 06; 45(6):1287-1297. View in: PubMed

  4. King A, Vena A, Hasin DS, deWit H, O'Connor SJ, Cao D. Subjective Responses to Alcohol in the Development and Maintenance of Alcohol Use Disorder. Am J Psychiatry. 2021 06; 178(6):560-571. View in: PubMed

  5. Chavarria J, Fridberg DJ, Obst E, Zimmermann US, King AC. Subjective alcohol responses in high- and low-risk adolescents: results from the Dresden Longitudinal Study on Alcohol Use in Young Adults. Addiction. 2021 07; 116(7):1716-1724. View in: PubMed

  6. Cotter TG, Ayoub F, King AC, Reddy KG, Charlton M. Practice Habits, Knowledge, and Attitudes of Hepatologists to Alcohol Use Disorder Medication: Sobering Gaps and Opportunities. Transplant Direct. 2020 Oct; 6(10):e603. View in: PubMed

  7. Vena A, Howe M, Fridberg D, Cao D, King AC. The Feasibility, Tolerability, and Safety of Administering a Very High Alcohol Dose to Drinkers with Alcohol Use Disorder. Alcohol Clin Exp Res. 2020 12; 44(12):2588-2597. View in: PubMed

  8. Vena A, Miloslavich K, Howe M, Cao D, King AC. Exposure to JUUL use: cue reactivity effects in young adult current and former smokers. Tob Control. 2020 May 23. View in: PubMed

  9. Ray LA, Grodin EN, Leggio L, Bechtholt AJ, Becker H, Feldstein Ewing SW, Jentsch JD, King AC, Mason BJ, O'Malley S, MacKillop J, Heilig M, Koob GF. The future of translational research on alcohol use disorder. Addict Biol. 2021 03; 26(2):e12903. View in: PubMed

  10. Asvat Y, King AC, Smith LJ, Lin X, Hedeker D, Henderson TO. Substance use behaviors in adolescent and young adult cancer patients: Associations with mental and physical health. Psychooncology. 2020 06; 29(6):1068-1076. View in: PubMed

  11. Fridberg DJ, Faria J, Cao D, King AC. Real-Time Mobile Monitoring of Drinking Episodes in Young Adult Heavy Drinkers: Development and Comparative Survey Study. JMIR Mhealth Uhealth. 2019 11 20; 7(11):e13765. View in: PubMed

  12. King AC, Cao D, deWit H, O'Connor SJ, Hasin DS. The role of alcohol response phenotypes in the risk for alcohol use disorder. BJPsych Open. 2019 Apr 22; 5(3):e38. View in: PubMed

  13. Vena A, Miloslavich K, Cao D, King A. Cue salience of the use of an electronic nicotine delivery system (ENDS) device marketed to women. Addict Behav. 2020 01; 100:106116. View in: PubMed

  14. Berey BL, Leeman RF, Chavarria J, King AC. Relationships between generalized impulsivity and subjective stimulant and sedative responses following alcohol administration. Psychol Addict Behav. 2019 Nov; 33(7):616-625. View in: PubMed

  15. Roche DJO, Trela CJ, Argos M, Jasmine F, Kibriya MG, Ahsan H, King AC. Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial. Alcohol Alcohol. 2019 Jan 09; 54(5):559-565. View in: PubMed

  16. Chavarria J, Liu M, Kast L, Salem E, King AC. A pilot study of Counsel to Quit®: Evaluating an Ask Advise Refer (AAR)-based tobacco cessation training for medical and mental healthcare providers. J Subst Abuse Treat. 2019 04; 99:163-170. View in: PubMed

  17. Vena A, Howe M, Cao D, King A. The role of E-liquid vegetable glycerin and exhaled aerosol on cue reactivity to tank-based electronic nicotine delivery systems (ENDS). Psychopharmacology (Berl). 2019 Jul; 236(7):2083-2092. View in: PubMed

  18. Grant JE, Lust K, Fridberg DJ, King AC, Chamberlain SR. E-cigarette use (vaping) is associated with illicit drug use, mental health problems, and impulsivity in university students. Ann Clin Psychiatry. 2019 02; 31(1):27-35. View in: PubMed

  19. Schacht JP, Anton RF, McNamara PJ, Im Y, King AC. The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms. Addict Biol. 2019 09; 24(5):1109-1118. View in: PubMed

  20. Matthews AK, Steffen AD, Kuhns LM, Ruiz RA, Ross NA, Burke LA, Li CC, King AC. Evaluation of a Randomized Clinical Trial Comparing the Effectiveness of a Culturally Targeted and Nontargeted Smoking Cessation Intervention for Lesbian, Gay, Bisexual, and Transgender Smokers. Nicotine Tob Res. 2019 10 26; 21(11):1506-1516. View in: PubMed

  21. Vena A, King A, Lee R, de Wit H. Intranasal Oxytocin Does Not Modulate Responses to Alcohol in Social Drinkers. Alcohol Clin Exp Res. 2018 09; 42(9):1725-1734. View in: PubMed

  22. Chavarria J, Rueger SY, King AC. Hangover in Post-College-Aged Drinkers: Psychometric Properties of the Hangover Symptom Scale (HSS) and the Hangover Symptom Scale-Short Form (HSS-5). Alcohol Clin Exp Res. 2018 06; 42(6):1122-1131. View in: PubMed

  23. Fridberg DJ, Rueger SY, Smith P, King AC. Association of Anticipated and Laboratory-Derived Alcohol Stimulation, Sedation, and Reward. Alcohol Clin Exp Res. 2017 Jul; 41(7):1361-1369. View in: PubMed

  24. Smith LJ, McNamara PJ, King AC. Optimizing follow-up and study retention in the 21st century: Advances from the front line in alcohol and tobacco research. Drug Alcohol Depend. 2017 06 01; 175:171-178. View in: PubMed

  25. Hitsman B, Baker AL, King A. Rebuttal From Dr Hitsman et al. Chest. 2017 09; 152(3):472-473. View in: PubMed

  26. Hitsman B, Baker AL, King A. POINT: Are Advanced Practice Professionals More Likely to Achieve Better Tobacco Cessation Results than Physicians? Yes. Chest. 2017 09; 152(3):466-469. View in: PubMed

  27. King AC, Smith LJ, McNamara PJ, Cao D. Second Generation Electronic Nicotine Delivery System Vape Pen Exposure Generalizes as a Smoking Cue. Nicotine Tob Res. 2018 01 05; 20(2):246-252. View in: PubMed

  28. Matthews AK, Cesario J, Ruiz R, Ross N, King A. A Qualitative Study of the Barriers to and Facilitators of Smoking Cessation Among Lesbian, Gay, Bisexual, and Transgender Smokers Who Are Interested in Quitting. LGBT Health. 2017 02; 4(1):24-33. View in: PubMed

  29. Coccaro EF, Keedy SK, Gorka SM, King AC, Fanning JR, Lee RJ, Phan KL. Differential fMRI BOLD responses in amygdala in intermittent explosive disorder as a function of past Alcohol Use Disorder. Psychiatry Res Neuroimaging. 2016 Nov 30; 257:5-10. View in: PubMed

  30. Miller MA, Bershad A, King AC, Lee R, de Wit H. Intranasal oxytocin dampens cue-elicited cigarette craving in daily smokers: a pilot study. Behav Pharmacol. 2016 12; 27(8):697-703. View in: PubMed

  31. Fucito LM, Toll BA, Roos CR, King AC. Smokers' Treatment Expectancies Predict Smoking Cessation Success. J Smok Cessat. 2016 Sep; 11(3):143-149. View in: PubMed

  32. Coccaro EF, Fridberg DJ, Fanning JR, Grant JE, King AC, Lee R. Substance use disorders: Relationship with intermittent explosive disorder and with aggression, anger, and impulsivity. J Psychiatr Res. 2016 10; 81:127-32. View in: PubMed

  33. Roche DJ, Ray LA, Yardley MM, King AC. Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers. Curr Addict Rep. 2016 Mar; 3(1):125-137. View in: PubMed

  34. Cao D, Zhuang X, Kang P, Hong SW, King AC. Acute Alcohol Drinking Promotes Piecemeal Percepts during Binocular Rivalry. Front Psychol. 2016; 7:489. View in: PubMed

  35. Hu HX, Zang GB, Liu ZL, Rueger SY, McNamara P, King AC, Hao W. Different Subjective and Objective Responses to Alcohol Among Heavy and Light Drinkers of Han and Uyghur Nationalities in China. J Addict Nurs. 2015 Oct-Dec; 26(4):191-202. View in: PubMed

  36. King AC, Smith LJ, Fridberg DJ, Matthews AK, McNamara PJ, Cao D. Exposure to electronic nicotine delivery systems (ENDS) visual imagery increases smoking urge and desire. Psychol Addict Behav. 2016 Feb; 30(1):106-12. View in: PubMed

  37. Fridberg DJ, Cao D, King AC. Integrating alcohol response feedback in a brief intervention for young adult heavy drinkers who smoke: A pilot study. Drug Alcohol Depend. 2015 Oct 01; 155:293-7. View in: PubMed

  38. Zhuang X, Kang P, King A, Cao D. Alcohol Intoxication Impairs Mesopic Rod and Cone Temporal Processing in Social Drinkers. Alcohol Clin Exp Res. 2015 Sep; 39(9):1842-9. View in: PubMed

  39. King AC, Hasin D, O'Connor SJ, McNamara PJ, Cao D. A Prospective 5-Year Re-examination of Alcohol Response in Heavy Drinkers Progressing in Alcohol Use Disorder. Biol Psychiatry. 2016 Mar 15; 79(6):489-98. View in: PubMed

  40. Bress A, Kittles R, Wing C, Hooker SE, King A. Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African Americans: an analysis of a randomized controlled trial. Pharmacogenet Genomics. 2015 Jun; 25(6):305-12. View in: PubMed

  41. Matthews AK, McConnell EA, Li CC, Vargas MC, King A. Design of a comparative effectiveness evaluation of a culturally tailored versus standard community-based smoking cessation treatment program for LGBT smokers. BMC Psychol. 2014; 2(1):12. View in: PubMed

  42. Roche DJ, King AC. Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase. Psychoneuroendocrinology. 2015 Feb; 52:59-71. View in: PubMed

  43. Fridberg DJ, Cao D, Grant JE, King AC. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking. Alcohol Clin Exp Res. 2014 Oct; 38(10):2622-9. View in: PubMed

  44. Rueger SY, Hu H, McNamara P, Cao D, Hao W, King AC. Differences in subjective response to alcohol in heavy- and light-drinking Chinese men versus Caucasian American men. Addiction. 2015 Jan; 110(1):91-9. View in: PubMed

  45. Asvat Y, Cao D, Africk JJ, Matthews A, King A. Feasibility and effectiveness of a community-based smoking cessation intervention in a racially diverse, urban smoker cohort. Am J Public Health. 2014 Sep; 104 Suppl 4:S620-7. View in: PubMed

  46. King AC, Smith LJ, McNamara PJ, Matthews AK, Fridberg DJ. Passive exposure to electronic cigarette (e-cigarette) use increases desire for combustible and e-cigarettes in young adult smokers. Tob Control. 2015 Sep; 24(5):501-4. View in: PubMed

  47. Roche DJ, Palmeri MD, King AC. Acute alcohol response phenotype in heavy social drinkers is robust and reproducible. Alcohol Clin Exp Res. 2014 Mar; 38(3):844-52. View in: PubMed

  48. King AC, McNamara PJ, Hasin DS, Cao D. Alcohol challenge responses predict future alcohol use disorder symptoms: a 6-year prospective study. Biol Psychiatry. 2014 May 15; 75(10):798-806. View in: PubMed

  49. King A, Cao D, Zhang L, Rueger SY. Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trial. Addiction. 2013 Oct; 108(10):1836-44. View in: PubMed

  50. Roche DJ, King AC, Cohoon AJ, Lovallo WR. Hormonal contraceptive use diminishes salivary cortisol response to psychosocial stress and naltrexone in healthy women. Pharmacol Biochem Behav. 2013 Aug; 109:84-90. View in: PubMed

  51. Gorka SM, Fitzgerald DA, King AC, Phan KL. Alcohol attenuates amygdala-frontal connectivity during processing social signals in heavy social drinkers: a preliminary pharmaco-fMRI study. Psychopharmacology (Berl). 2013 Sep; 229(1):141-54. View in: PubMed

  52. Sivasithamparam J, Visk CA, Cohen EE, King AC. Modifiable risk behaviors in patients with head and neck cancer. Cancer. 2013 Jul 01; 119(13):2419-26. View in: PubMed

  53. Matthews AK, Conrad M, Kuhns L, Vargas M, King AC. Project Exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care STDS. 2013 Jan; 27(1):22-32. View in: PubMed

  54. Morean ME, de Wit H, King AC, Sofuoglu M, Rueger SY, O'Malley SS. The drug effects questionnaire: psychometric support across three drug types. Psychopharmacology (Berl). 2013 May; 227(1):177-92. View in: PubMed

  55. King AC, Cao D, Zhang L, O'Malley SS. Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial. Biol Psychiatry. 2013 May 01; 73(9):924-30. View in: PubMed

  56. Zhuang X, King A, McNamara P, Pokorny J, Cao D. Differential effects of alcohol on contrast processing mediated by the magnocellular and parvocellular pathways. J Vis. 2012 Oct 22; 12(11). View in: PubMed

  57. Rueger SY, King AC. Validation of the brief Biphasic Alcohol Effects Scale (B-BAES). Alcohol Clin Exp Res. 2013 Mar; 37(3):470-6. View in: PubMed

  58. King AC, Cao D, O'Malley SS, Kranzler HR, Cai X, deWit H, Matthews AK, Stachoviak RJ. Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. J Clin Psychopharmacol. 2012 Oct; 32(5):630-6. View in: PubMed

  59. Conrad M, McNamara P, King A. Alternative substance paradigm: effectiveness of beverage blinding and effects on acute alcohol responses. Exp Clin Psychopharmacol. 2012 Oct; 20(5):382-9. View in: PubMed

  60. Rueger SY, Trela CJ, Palmeri M, King AC. Self-administered web-based timeline followback procedure for drinking and smoking behaviors in young adults. J Stud Alcohol Drugs. 2012 Sep; 73(5):829-33. View in: PubMed

  61. Lovallo WR, King AC, Farag NH, Sorocco KH, Cohoon AJ, Vincent AS. Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project. Psychoneuroendocrinology. 2012 Dec; 37(12):1922-8. View in: PubMed

  62. Childs E, Roche DJ, King AC, de Wit H. Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements. Alcohol Clin Exp Res. 2012 May; 36(5):906-14. View in: PubMed

  63. Plebani JG, Ray LA, Morean ME, Corbin WR, MacKillop J, Amlung M, King AC. Human laboratory paradigms in alcohol research. Alcohol Clin Exp Res. 2012 Jun; 36(6):972-83. View in: PubMed

  64. King AC, Roche DJ, Rueger SY. Subjective responses to alcohol: a paradigm shift may be brewing. Alcohol Clin Exp Res. 2011 Oct; 35(10):1726-8. View in: PubMed

  65. King AC, de Wit H, McNamara PJ, Cao D. Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking. Arch Gen Psychiatry. 2011 Apr; 68(4):389-99. View in: PubMed

  66. King AC, Cao D, Southard CC, Matthews A. Racial differences in eligibility and enrollment in a smoking cessation clinical trial. Health Psychol. 2011 Jan; 30(1):40-8. View in: PubMed

  67. Sripada CS, Angstadt M, McNamara P, King AC, Phan KL. Effects of alcohol on brain responses to social signals of threat in humans. Neuroimage. 2011 Mar 01; 55(1):371-80. View in: PubMed

  68. Sánchez-Johnsen LA, Carpentier MR, King AC. Race and sex associations to weight concerns among urban African American and Caucasian smokers. Addict Behav. 2011 Jan-Feb; 36(1-2):14-7. View in: PubMed

  69. Roche DJ, King AC. Alcohol impairment of saccadic and smooth pursuit eye movements: impact of risk factors for alcohol dependence. Psychopharmacology (Berl). 2010 Sep; 212(1):33-44. View in: PubMed

  70. Hamidovic A, Childs E, Conrad M, King A, de Wit H. Stress-induced changes in mood and cortisol release predict mood effects of amphetamine. Drug Alcohol Depend. 2010 Jun 01; 109(1-3):175-80. View in: PubMed

  71. Shah LM, King AC, Basu A, Krishnan JA, Borden WB, Meltzer D, Arora V. Effect of clinician advice and patient preparedness to quit on subsequent quit attempts in hospitalized smokers. J Hosp Med. 2010 Jan; 5(1):26-32. View in: PubMed

  72. King A, McNamara P, Angstadt M, Phan KL. Neural substrates of alcohol-induced smoking urge in heavy drinking nondaily smokers. Neuropsychopharmacology. 2010 Feb; 35(3):692-701. View in: PubMed

  73. Roche DJ, Childs E, Epstein AM, King AC. Acute HPA axis response to naltrexone differs in female vs. male smokers. Psychoneuroendocrinology. 2010 May; 35(4):596-606. View in: PubMed

  74. King A, McNamara P, Conrad M, Cao D. Alcohol-induced increases in smoking behavior for nicotinized and denicotinized cigarettes in men and women. Psychopharmacology (Berl). 2009 Nov; 207(1):107-17. View in: PubMed

  75. Matthews AK, Sánchez-Johnsen L, King A. Development of a culturally targeted smoking cessation intervention for African American smokers. J Community Health. 2009 Dec; 34(6):480-92. View in: PubMed

  76. Rueger SY, McNamara PJ, King AC. Expanding the utility of the Biphasic Alcohol Effects Scale (BAES) and initial psychometric support for the Brief-BAES (B-BAES). Alcohol Clin Exp Res. 2009 May; 33(5):916-24. View in: PubMed

  77. King A, Cao D, Vanier C, Wilcox T. Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study. Alcohol Clin Exp Res. 2009 Jun; 33(6):1044-50. View in: PubMed

  78. King A, Epstein A, Conrad M, McNamara P, Cao D. Sex differences in the relationship between alcohol-associated smoking urge and behavior: a pilot study. Am J Addict. 2008 Sep-Oct; 17(5):347-53. View in: PubMed

  79. King A, Sánchez-Johnsen L, Van Orman S, Cao D, Matthews A. A pilot community-based intensive smoking cessation intervention in African Americans: feasibility, acceptability and early outcome indicators. J Natl Med Assoc. 2008 Feb; 100(2):208-17. View in: PubMed

  80. Brumback T, Cao D, King A. Effects of alcohol on psychomotor performance and perceived impairment in heavy binge social drinkers. Drug Alcohol Depend. 2007 Nov 02; 91(1):10-7. View in: PubMed

  81. Tuvlin JA, Raza SS, Bracamonte S, Julian C, Hanauer SB, Nicolae DL, King AC, Cho JH. Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts. Inflamm Bowel Dis. 2007 May; 13(5):573-9. View in: PubMed

  82. King A, de Wit H, Riley RC, Cao D, Niaura R, Hatsukami D. Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences. Nicotine Tob Res. 2006 Oct; 8(5):671-82. View in: PubMed

  83. Epstein AM, Sher TG, Young MA, King AC. Tobacco chippers show robust increases in smoking urge after alcohol consumption. Psychopharmacology (Berl). 2007 Feb; 190(3):321-9. View in: PubMed

  84. King A, Munisamy G, de Wit H, Lin S. Attenuated cortisol response to alcohol in heavy social drinkers. Int J Psychophysiol. 2006 Mar; 59(3):203-9. View in: PubMed

  85. King AC, Epstein AM. Alcohol dose-dependent increases in smoking urge in light smokers. Alcohol Clin Exp Res. 2005 Apr; 29(4):547-52. View in: PubMed

  86. King AC, Canada SA. Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. J Subst Abuse Treat. 2004 Apr; 26(3):189-95. View in: PubMed

  87. King AC, Byars JA. Alcohol-induced performance impairment in heavy episodic and light social drinkers. J Stud Alcohol. 2004 Jan; 65(1):27-36. View in: PubMed

  88. Epstein AM, King AC. Naltrexone attenuates acute cigarette smoking behavior. Pharmacol Biochem Behav. 2004 Jan; 77(1):29-37. View in: PubMed

  89. Bernardy NC, King AC, Lovallo WR. Cardiovascular responses to physical and psychological stress in female alcoholics with transitory hypertension after early abstinence. Alcohol Clin Exp Res. 2003 Sep; 27(9):1489-98. View in: PubMed

  90. King AC, Bernardy NC, Hauner K. Stressful events, personality, and mood disturbance: gender differences in alcoholics and problem drinkers. Addict Behav. 2003 Jan-Feb; 28(1):171-87. View in: PubMed

  91. King AC. Role of naltrexone in initial smoking cessation: preliminary findings. Alcohol Clin Exp Res. 2002 Dec; 26(12):1942-4. View in: PubMed

  92. Errico AL, King AC, Lovallo WR, Parsons OA. Cortisol dysregulation and cognitive impairment in abstinent male alcoholics. Alcohol Clin Exp Res. 2002 Aug; 26(8):1198-204. View in: PubMed

  93. King AC, Houle T, de Wit H, Holdstock L, Schuster A. Biphasic alcohol response differs in heavy versus light drinkers. Alcohol Clin Exp Res. 2002 Jun; 26(6):827-35. View in: PubMed

  94. King AC, Schluger J, Gunduz M, Borg L, Perret G, Ho A, Kreek MJ. Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism. Neuropsychopharmacology. 2002 Jun; 26(6):778-88. View in: PubMed

  95. King AC, Meyer PJ. Naltrexone alteration of acute smoking response in nicotine-dependent subjects. Pharmacol Biochem Behav. 2000 Jul; 66(3):563-72. View in: PubMed

  96. Holdstock L, King AC, de Wit H. Subjective and objective responses to ethanol in moderate/heavy and light social drinkers. Alcohol Clin Exp Res. 2000 Jun; 24(6):789-94. View in: PubMed